CNS embryonal tumors, a formidable challenge in pediatric oncology, arise from embryonic cells within the central nervous system. Delving into their molecular underpinnings, researchers uncover intricate genetic anomalies and aberrant signaling pathways fueling their aggressive growth. With cutting-edge imaging and molecular profiling techniques, clinicians refine diagnostic precision and tailor therapeutic strategies.
Recent strides spotlight immunotherapy and targeted interventions, presenting potential breakthroughs in preclinical and clinical realms. By deciphering the intricate molecular landscapes of these tumors, the research community endeavors to forge novel treatment modalities, striving to ameliorate outcomes and enhance the lives of afflicted children.



Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States
Title : Graphene quantum dots: A new frontier for photodynamic therapy
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil